Aceclofenac and Analgesic Nephropathy : A Transcendent Adverse Effect of Concern

Aceclofenac and Analgesic Nephropathy

Authors

  • Amee Pandya First Year Resident, Department of Pharmacology, Smt.NHL Municipal Medical College, Ahmedabad, Gujarat, India-380006
  • Sapna Gupta Assistant Professor, Department of Emergency Medicine, Smt.NHL Municipal Medical College, Ahmedabad, Gujarat, India-380006
  • Jaldipsinh Gohil Second Year Resident, Department of Emergency Medicine, Smt.NHL Municipal Medical College, Ahmedabad, Gujarat, India-380006
  • Supriya Malhotra Professor and Head, Department of Pharmacology, Smt.NHL Municipal Medical College, Ahmedabad, Gujarat, India-380006
  • Pankaj Patel Dean, Smt.NHL Municipal Medical College, Ahmedabad, Gujarat, India-380006

DOI:

https://doi.org/10.70284/njirm.v10i1.2503

Keywords:

Aceclofenac, Acute renal failure, Analgesic nephropathy, Pharmacovigilance

Abstract

To eliminate the preventable deaths due to Acute Kidney Failure(ARF), especially due to chronic usage of over the counter non-steroidal anti-inflammatory drugs (NSAID) medications should be a pre-defined healthcare goal. Ever after the discovery of selective cyclooxygenase-2 (COX-2) inhibitors, nephrotoxicity still remains a concern. Here we are highlighting a case of Aceclofenac induced Acute on chronic renal disease exemplifying unregulated use of NSAIDs is an under recognized and potentially dangerous problem and that constant pharmacovigilance is the key to detect such events. This case was notified and uploaded to Vigiflow with I’d 2018-58102. Even after the availability of diversity of NSAIDs, a renal safe NSAID is yet to be discovered. [Pandya A  Natl J Integr Res Med, 2019; 10(1):51-53]

References

1. Waddington F, Naunton M, Thomas J. Paracetamol and analgesic nephropathy: Are you kidneying me?. Int Med Case Rep J. 2014;8:1-5.
2. Abdulla A, Adams N, Bone M, Elliot AM, Gaffin J, Jones D, Knaggs R, Martin D, Sampson L, Schofield P. Guidance on the management of pain in older people. Age Ageing. 2013;42:i1–i57
3. Ejaz P, Bhojani K, Joshi V. NSAIDS and kidney. J Assoc Physicians India. 2004;52:632–640.
4. Grosser T, Smyth EM, FitzGerald GA. Pharmacotherapy of Inflammation, Fever, Pain, and Gout. In: Brunton LB, Hilal-Dandan R, Knollmann BC(eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. 13th ed. New York, NY: McGraw-Hill; 2018: 689-691.
5. Crofford L. Rational use of analgesic and antiinflammatory drugs. N Engl J Med. 2001;345(25):1844–1846.
6. Broe M, Elseviers M. Over-the-counter analgesic use. J Am Soc Nephrol. 2009;20(10):2098–2103.
7. Pérez, S.; García, L.A.; Raiford, D.S.; Duque, A.; Ris, J.; Non-steroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure. Arch. Intern. Med. 1996, 156, 2433-2439.
8. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med. 1994;331(25):1675–1679.
9. Feinstein A, Heinemann L, Curhan G, Delzell E, Deschepper PJ, Fox JM, Graf H, Luft FC, Michielson P, Mihatsch MJ, Suissa S, Woude FV, Willich S. Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy. Kidney Int. 2000;58(6):2259–2264.
10. Dixit M, Doan T, Kirschner R, Dixit N. Significant Acute Kidney Injury Due to Non-steroidal Anti-inflammatory Drugs: Inpatient Setting. Pharmaceuticals (Basel). 2010;3(4):1279-1285.

Downloads

Published

2019-03-01

How to Cite

Pandya, A., Gupta, S., Gohil, J., Malhotra, S., & Patel, P. (2019). Aceclofenac and Analgesic Nephropathy : A Transcendent Adverse Effect of Concern: Aceclofenac and Analgesic Nephropathy. National Journal of Integrated Research in Medicine, 10(1), 51–53. https://doi.org/10.70284/njirm.v10i1.2503

Issue

Section

Case Report

Most read articles by the same author(s)